Clinical Trial Update: Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD) [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for a selective, high affinity enkephalinergic agonist in Anxious Major Depressive Disorder, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxious Major Depressive Disorder

Drugs mentioned

• Unspecified enkephalinergic agonist

Snippet

Sponsor: AstraZeneca | Conditions: Anxious Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2012-11-08